Needham & Company Reiterates Buy Rating, $20 PT on CorMedix (CRMD), Sees Latest Developments Removing Some Overhang

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

Go back to Needham & Company Reiterates Buy Rating, $20 PT on CorMedix (CRMD), Sees Latest Developments Removing Some Overhang
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 8.23 +0.06 (0.73%)
Previous Close $8.17    52 Week High $4.54 
Open $8.19    52 Week Low $1.15 
Day High $8.27    P/E N/A 
Day Low $8.09    EPS $-0.55 
Volume 835,955